Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
10:00am, Monday, 30'th Dec 2024
I review here the stocks of six quality companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends. Dividend growth investing is
Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst
09:00am, Sunday, 29'th Dec 2024
Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight-loss shot CagriSema was found to help recipients lose less weight than previously forecasted, BMO Capital Markets c
3 Stocks That Could Be Monster Winners in 2025
06:47am, Sunday, 29'th Dec 2024
What do many kids like most about the coming of a new year? The fireworks.
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry Leaders
05:39am, Sunday, 29'th Dec 2024
If you're looking for top stocks, there's no need to reinvent the wheel. The Securities and Exchange Commission makes it a breeze to follow the world's greatest investors.
Is Eli Lilly Stock a Buy?
04:35am, Sunday, 29'th Dec 2024
While Novo Nordisk's (NYSE: NVO) Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category doing well. While Elon Musk recently showed
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
06:05am, Saturday, 28'th Dec 2024
If you're too busy to keep monitoring your stock portfolio every other day, then investing in stocks that won't cause you a lot of headache down the road is a necessity. In order to do so, it's import
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
04:30am, Friday, 27'th Dec 2024
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo N
Better Buy: Eli Lilly vs. Novo Nordisk.
10:15am, Thursday, 26'th Dec 2024
It seems like just yesterday that vaccines used to combat the COVID-19 pandemic were all anyone in the medical world could talk about. Companies such as Pfizer, Moderna, and Johnson & Johnson captured
Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy?
08:00am, Thursday, 26'th Dec 2024
Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk's (NVO -1.51%) stock crashed by 19% on Dec. 20, after the company reported results from a late-stage cli
CagriSema still keeps the Novo Nordisk story in tact, says Barclays' Emily Field
07:50am, Thursday, 26'th Dec 2024
Emily Field, Barclays head of European pharmaceutical research, joins 'Squawk Box' to discuss the state of the weight loss drug market, disappointing trial results of Novo Nordisk's experimental Cagri
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
04:25am, Thursday, 26'th Dec 2024
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo N
Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note
06:51pm, Tuesday, 24'th Dec 2024
In the latest trading session, Novo Nordisk (NVO) closed at $87.37, marking a -1.51% move from the previous day.
Novo Nordisk: Aggressive Dip-Buying Opportunity Has Finally Arrived
11:30am, Tuesday, 24'th Dec 2024
Novo Nordisk's recent CagriSema study disappointed and led to a massive selloff as investor pessimism deepened. Eli Lilly stock's relative outperformance could strengthen its bullish case, but NVO isn
Novo Nordisk Stock Plunges 18% in a Week: What Should Investors Do?
09:51am, Tuesday, 24'th Dec 2024
NVO stock declines after a recent obesity study setback and intense competition from market rivals but offers long-term growth potential.
Will Novo Nordisk (NVO) Stock Recover To $145 Levels?
12:15am, Tuesday, 24'th Dec 2024
Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of this year. In contrast, its closest peer, Eli Lilly stock is down 15% over
